[A clinical study of Kaposi's sarcoma associated with the acquired immunodeficiency syndrome]

V Pintado García1, M López-Dupla, E Valencia Ortega

  • 1Servicio de Medicina Interna, Hospital La Paz, Universidad Autónoma, Madrid.

Anales De Medicina Interna (Madrid, Spain : 1984)
|December 1, 1992
PubMed

Insights

Kaposi's sarcoma in patients with acquired immunodeficiency syndrome (AIDS) often presents as widespread skin lesions and frequently affects internal organs. Survival is poor, with opportunistic infections being the primary cause of death.

Area of Science:

  • Oncology
  • Infectious Diseases
  • Immunology

Context:

  • Retrospective study of 35 Kaposi's sarcoma (KS) cases among 460 patients with acquired immunodeficiency syndrome (AIDS) over 10 years.
  • KS was the initial diagnostic criterion for AIDS in 25 patients.
  • Predominant affected demographic: males, mean age 38, 88% from homosexual risk group.

Purpose:

  • To analyze the clinical and evolutive characteristics of Kaposi's sarcoma in patients with AIDS.
  • To evaluate the incidence, staging, localization, immunological status, treatment response, and survival rates of KS in this population.

Summary:

  • High incidence of KS (7.6%) in AIDS patients, primarily affecting skin, mucosa, and visceral organs (digestive tract, lung, lymph nodes).
  • Immunological findings include significant lymphopenia (74%), reduced T4 lymphocytes (93%), and inverted T4/T8 ratio (96%).
  • Treatment response to chemotherapy, interferon, or radiotherapy was limited, with a 48% mortality rate and a median survival of 13 months, often due to opportunistic infections.

Impact:

  • Confirms the aggressive nature of AIDS-associated Kaposi's sarcoma, characterized by disseminated lesions, visceral involvement, and poor treatment outcomes.
  • Highlights the critical role of opportunistic infections in mortality.
  • Suggests that observed lower incidence may be linked to variations in HIV risk group distribution.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...